Sirturo, also known as bedaquiline, is a medication used in the treatment of multidrug-resistant tuberculosis (MDR-TB). This drug is a valuable addition to the arsenal of medications available to combat this challenging and potentially deadly infection.

Sirturo works by inhibiting an enzyme called ATP synthase, which is essential for the energy production of the bacteria that cause tuberculosis. By targeting this specific mechanism, Sirturo is able to effectively kill the bacteria and help to clear the infection.

It is important to note that Sirturo should always be used in combination with other medications for MDR-TB, as part of a comprehensive treatment plan. This drug is typically reserved for cases where other treatments have failed, or when the infection is resistant to multiple other medications.

As with any medication, there are potential side effects associated with Sirturo. These can include nausea, headache, and changes in liver function tests. It is important for patients to be monitored closely by their healthcare provider while taking this medication to ensure that any side effects are promptly addressed.

Overall, Sirturo has been shown to be an effective and important tool in the treatment of multidrug-resistant tuberculosis. It is crucial for patients to work closely with their healthcare team to ensure that they are receiving the appropriate treatment and support while taking this medication. With proper monitoring and adherence to treatment guidelines, Sirturo can help to improve outcomes for patients with MDR-TB.